12月19日 截至收盘。2025年12月19日物企市值涨幅周排行榜出炉。63家上市物企总市值2674.16亿元， 环比增加约2382.34亿元，涨幅816.37%。其中，57家物企市值持平，占90%；4家物企市值上涨，市值 增加136.41亿。2家物企市值下跌。 榜单显示，市值涨幅排名第一的是中天服务，涨幅达35.82%，市值 增加6.44亿元，总市值24.43亿元，行业领涨。榜单涨幅前十依次为中天服务、珠江股份、新大正、招商 积余、特发服务、南都物业、润华服务、领悦服务集团、苏新服务和力高健康生活。 市值跌幅排名第 一的是碧桂园服务 ，跌幅达0%，市值缩水0亿元，总市值190.24亿元，行业领跌。榜单跌幅前十依次为 碧桂园服务、绿城服务、彩生活、中海物业、雅生活服务、保利物业、中奥到家、祈福生活服务、浦江 中国和兴业物联。 ...

格隆汇12月15日丨骏鼎达(301538.SZ)在投资者互动平台表示,截至目前，公司未与特斯拉建立直接业务 合作关系。公司目前正与机器人领域相关主体处于业务对接阶段，相关产品的后续合作存在不确定性。 ...

格隆汇12月15日丨骏鼎达(301538.SZ)在互动平台表示，截至目前，公司未与特斯拉建立直接业务合作 关系。公司目前正与机器人领域相关主体处于业务对接阶段，相关产品的后续合作存在不确定性。 ...

格隆汇12月8日丨骏鼎达(301538.SZ)在投资者互动平台表示，首先需说明，公司并未专注于柔性传感与 电子皮肤技术，感谢对公司业务的关注。公司的主营业务是高分子改性保护材料的研发、生产和销售， 主要产品包括功能性保护套管等，产品主要为线束系统和流体管路提供耐磨等安全防护。公司暂不涉及 传感器保护罩、封装外壳的生产。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中奧到家集團有限公司 呈交日期: 2025年12月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01538 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 8,000,000,000 | HKD | | 0.01 | HKD | | 80,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 8,000,000,000 | HKD | | 0.01 | HKD | | 80,000,000 | 本月底法定/註冊 ...

Group 1 - The core point of the article is that Jun Ding Da (301538.SZ) announced a restricted stock incentive plan for 2025, proposing to grant a total of 784,000 shares, which accounts for 1.00% of the company's total share capital of 78.4 million shares at the time of the announcement [1] - The incentive plan will initially grant shares to a total of 85 individuals [1] - The grant price for the second category of restricted stock is set at 38.33 yuan per share [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中奧到家集團有限公司 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01538 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 8,000,000,000 | HKD | | 0.01 | HKD | | 80,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 8,000,000,000 | HKD | | 0.01 | HKD | | 80,000,000 | 本月底法定/註冊 ...

Group 1 - The core viewpoint of the news is that Jun Ding Da (301538.SZ) reported its Q3 2025 results, highlighting the institutional investor holdings and changes in share ownership [1] - As of October 27, 2025, a total of 9 institutional investors disclosed holdings in Jun Ding Da A-shares, with a combined holding of 11.4673 million shares, accounting for 14.63% of the total share capital [1] - The institutional investor holding ratio decreased by 0.43 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, there was an increase in holdings from one public fund, namely Guotai Valuation Advantage Mixed (LOF) A, with an increase in holding ratio of 2.41% [2] - A total of 64 public funds did not disclose their holdings in this period compared to the previous quarter, including funds such as Nuoan Pioneer Mixed A and Baodao Growth Smart Navigation Stock A [2]

Core Viewpoint - Jun Ding Da (301538.SZ) reported a strong performance in the first three quarters of 2025, with significant year-on-year growth in both revenue and net profit [1] Financial Performance - The company's operating revenue for the first three quarters reached 728 million yuan, representing a year-on-year increase of 23.43% [1] - The net profit attributable to shareholders of the listed company was 137 million yuan, showing a year-on-year growth of 18.82% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 133 million yuan, reflecting a year-on-year increase of 19.45% [1] - Basic earnings per share stood at 1.7501 yuan [1]

Core Viewpoint - The company, Jun Ding Da (301538.SZ), is currently in the testing and validation phase for its tendon products, with research and development progressing according to plan, but has not yet reached a significant milestone that requires disclosure [1] Group 1 - The tendon products are still undergoing testing and validation [1] - Research and development work is advancing as per the established schedule [1] - The projects under development are characterized by long R&D cycles and high uncertainty [1] Group 2 - The testing and validation process involves multiple technical calibrations and scenario adaptations [1] - Progress needs to be made gradually [1]